How Easy Is This?

On November 22, 2004, the diabetes business unit of Medtronic, Inc., and Novo Nordisk announced an agreement to develop the first prefilled cartridges designed for use with Paradigm external insulin pumps.

According to the two companies, “Prefilled cartridges containing NovoLog are expected to offer a convenient option for people using Paradigm pump therapy.”

In addition to developing the prefilled cartridges, the companies intend to start clinical studies to demonstrate the advantages of NovoLog insulin and Paradigm pump therapy over other insulin therapies.

Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.